Skip to main content
. 2014 Aug 13;50(2):238–248. doi: 10.1007/s00535-014-0979-2

Fig. 3.

Fig. 3

Mean decline in HCV RNA from baseline to week 6. bid twice daily, PR peginterferon alfa-2a and ribavirin. *Administered with peginterferon alfa-2a and ribavirin